Literature DB >> 27407849

Miltefosine: First Oral Drug for Treatment of Visceral Leishmaniasis.

V K Agrawal1, Zile Singh2.   

Abstract

Entities:  

Keywords:  Miltefosine; Visceral leishmaniasis

Year:  2011        PMID： 27407849      PMCID： PMC4923286          DOI： 10.1016/S0377-1237(06)80162-0

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  6 in total

Review 1.  Miltefosine: great expectations against visceral leishmaniasis.

Authors:  B More; H Bhatt; V Kukreja; S S Ainapure
Journal:  J Postgrad Med       Date:  2003 Jan-Mar       Impact factor: 1.476

Review 2.  The increase in risk factors for leishmaniasis worldwide.

Authors:  P Desjeux
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 May-Jun       Impact factor: 2.184

3.  Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis.

Authors:  Shyam Sundar; T K Jha; Herbert Sindermann; Klaus Junge; Peter Bachmann; Jonathan Berman
Journal:  Pediatr Infect Dis J       Date:  2003-05       Impact factor: 2.129

4.  Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions.

Authors:  M Rakotomanga; M Saint-Pierre-Chazalet; P M Loiseau
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

Review 5.  Miltefosine: an oral drug for visceral leishmaniasis.

Authors:  Rajniti Prasad; Ranjeet Kumar; B P Jaiswal; Utpal Kant Singh
Journal:  Indian J Pediatr       Date:  2004-02       Impact factor: 1.967

6.  Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India.

Authors:  Sujit K Bhattacharya; T K Jha; Shyam Sundar; C P Thakur; Juergen Engel; Herbert Sindermann; Klaus Junge; Juntra Karbwang; Anthony D M Bryceson; Jonathan D Berman
Journal:  Clin Infect Dis       Date:  2003-12-18       Impact factor: 9.079
  6 in total
  3 in total

1.  Mechanism of Action of Miltefosine on Leishmania donovani Involves the Impairment of Acidocalcisome Function and the Activation of the Sphingosine-Dependent Plasma Membrane Ca2+ Channel.

Authors:  Andrea K Pinto-Martinez; Jessica Rodriguez-Durán; Xenon Serrano-Martin; Vanessa Hernandez-Rodriguez; Gustavo Benaim
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

2.  Synthesis, Leishmanicidal, Trypanocidal, Antiproliferative Assay and Apoptotic Induction of (2-Phenoxypyridin-3-yl)naphthalene-1(2H)-one Derivatives.

Authors:  Zuleima Blanco; Esteban Fernandez-Moreira; Michael R Mijares; Carmen Celis; Gricelis Martínez; Juan B De Sanctis; Soňa Gurská; Petr Džubák; Marián Hajdůch; Ali Mijoba; Yael García; Xenón Serrano; Nahum Herrera; Jhonny Correa-Abril; Yonathan Parra; Jorge Ángel; Hegira Ramírez; Jaime E Charris
Journal:  Molecules       Date:  2022-08-31       Impact factor: 4.927

3.  Modeling and simulation study to identify threonine synthase as possible drug target in Leishmania major.

Authors:  Rohan J Meshram; Kamini T Bagul; Snehal U Aouti; Akshay M Shirsath; Harleen Duggal; Rajesh N Gacche
Journal:  Mol Divers       Date:  2020-07-31       Impact factor: 3.364
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.